Testosterone products, which are prescribed to treat low testosterone (“Low T”) in men, have become popular among young men seeking physical enhancement and older men who want to counter signs of aging. Recent studies, though, have suggested that “Low T Syndrome” treatment offers no proven benefits for healthy men. Rather, it seems that “Low T Syndrome” is an invention of pharmaceutical companies designed to sell treatment products.

Far worse, there is growing concern that these products have serious side effects and long-term risks, particularly related to the heart. Medical research has advised that men using testosterone may be at a significantly greater risk for a myriad of health issues, including cardiac events such as stroke, pulmonary embolism and death. (Increased Risk of Non-Fatal Myocardial Infarction Following Testosterone Prescription In Men, published January 2014; Association of Testosterone Therapy With Mortality, Myocardial Infarction, and Stoke in Men With Low Testosterone Levels, published November 2013).

Lawsuits Filed

In March 2015, the FDA issued a safety warning that testosterone drugs may increase the risk of stroke, heart attack and death in men taking FDA-approved testosterone products.

Over 1,000 lawsuits filed by men who say testosterone drugs caused their cardiovascular problems are pending in federal court. More specifically, men are filing lawsuits against the maker of Androgel and other Low-T product manufacturers. As the medical community learns more about adverse events from Low T therapies, drug makers’ statements about risks and benefits will come under more scrutiny.

What to Do

If you or someone you love has suffered serious medical conditions after taking testosterone products or supplements, call the low testosterone treatment attorneys at Nager, Romaine & Schneiberg Co., L.P.A. We will evaluate the feasibility of a lawsuit and determine whether you are entitled to compensation. Please contact us today at 216-289-4740, Toll Free from Ohio at (855) Got-Hurt, or by filling out our No-Risk Consultation form.